Roivant Sciences Ltd. (ROIV)

26.75 -0.05 (-0.19%) USD  |  NASDAQ  |  Feb 12, 16:00
26.15 -0.60 (-2.24%) Pre-Market: 09:03
More

Roivant Sciences EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Immunovant, Inc. Upgrade
GSK Plc Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Silence Therapeutics Plc Upgrade
Adaptimmune Therapeutics Plc Upgrade